METHYLOMIC_EU

DNA methylation markers to predict treatment
success of biologicals in Crohn’s disease, psoriasis and RheumatoidArthritis. @HorizonEU project GA No. 101095449

[METHYLOMIC_EU @methylomic]

🎬 𝗦𝗲𝗰𝗼𝗻𝗱 𝗠𝗘𝗧𝗛𝗬𝗟𝗢𝗠𝗜𝗖 𝗱𝗼𝗰𝘂𝗺𝗲𝗻𝘁𝗮𝗿𝘆 𝗻𝗼𝘄 𝗮𝘃𝗮𝗶𝗹𝗮𝗯𝗹𝗲 𝘄𝗶𝘁𝗵 𝘀𝘂𝗯𝘁𝗶𝘁𝗹𝗲𝘀 𝗶𝗻 𝘀𝗶𝘅 𝗹𝗮𝗻𝗴uages

👉 Watch it now and choose your subtitles: https://t.co/d6Q1NOwUMk

#IBD #CrohnsDisease #UlcerativeColitis #METHYLOMIC

[METHYLOMIC_EU @methylomic]

🎬 The film about the METHYLOMIC project '𝗧𝗵𝗲 𝗦𝗲𝗮𝗿𝗰𝗵 𝗳𝗼𝗿 𝗕𝗲𝘁𝘁𝗲𝗿 𝗕𝗶𝗼𝗺𝗮𝗿𝗸𝗲𝗿𝘀 𝗶𝗻 𝗜𝗕𝗗' is now available with English, Dutch, French, Hungarian, Italian, and Slovenian subtitles.

👉 Watch it now and choose your subtitles: https://t.co/OeBZn6WBt9

[METHYLOMIC_EU @methylomic]

On the METHYLOMIC project website, you will find a number of new pages about how you can participate in the OmiCrohn study.

At the bottom of this page, you will find links to the various new pages: https://t.co/Cm665Awi8P

#OmiCrohn #METHYLOMIC

[METHYLOMIC_EU @methylomic]

Inside the OmiCrohn Study >>Documentary: Epigenetics and the future of IBD care.

This video offers an introduction to the OMICROHN Study, developed within the Horizon Europe project METHYLOMIC.

https://t.co/Wk6CUTgTNr

[METHYLOMIC_EU @methylomic]

This video offers a closer look at the work of the Horizon Europe project METHYLOMIC. The video highlights the transformative potential of predictive biomarkers in the development of more effective and truly personalised treatments.

https://t.co/FJn3jr6Gov

#methylomic #IBD

[METHYLOMIC_EU @methylomic]

On 10 December 2025, IFCCA, in collaboration with the Horizon Europe project METHYLOMIC, brought together leading experts, patient advocates, and people living with IBD to discuss how precision medicine is moving from theory to real benefit.

https://t.co/Eh8vzGsY5L

[METHYLOMIC_EU @methylomic]

The sixth newsletter about the METHYLOMIC project has been published. Read the latest news: https://t.co/IELSBbhWSy

#METHYLOMIC #targetinghope #EPIPSORA #OMICROHN #Crohns #RheumatoidArthritis

[METHYLOMIC_EU @methylomic]

Vincent Joustra was awarded the 1st prize for the EPIC-CD study. This study aims to identify predictive biomarkers that can help personalize treatment strategies in Crohn’s disease by using blood-based DNA methylation signatures.

Read more: https://t.co/GQVnI8J2Xu

#METHYLOMIC

[METHYLOMIC_EU @methylomic]

Three questions for @tommasoparigi , clinician and researcher, San Raffaele Hospital and University about the METHYLOMIC Project.

Read his answers on our project website: https://t.co/1fy6KnCp3e

#METHYLOMIC #Crohns #research #IBD

[METHYLOMIC_EU @methylomic]

In this podcast, journalist Shula Tas interviews Prof. Geert D’Haens about how methylation research aims to improve treatment selection for Crohn’s disease, Rheumatoid Arthritis and Psoriasis through personalized medicine.

Watch it https://t.co/rGOVgkRwhA

#METHYLOMIC

[METHYLOMIC_EU @methylomic]

In this episode, representatives of IFCCA share their views on the OmiCrohn clinical trial and reflect on the potential impact it may have on the lives of people living with Crohn’s disease.

https://t.co/C6s0ZxxIGm

#METHYLOMIC #OMICROHN #MethylomicMatters #CrohnsDisease

[METHYLOMIC_EU @methylomic]

This podcast explores the Episora trial, a major study that uses AI to help determine which medication is most effective for each patient, offering a more efficient alternative to the current trial-and-error approach.

#METHYLOMIC #EPISORA #RheumatoidArthritis #AI #trial

[METHYLOMIC_EU @methylomic]

Since the last update at the end of May, more participants have been enrolled in the OMICROHN study. And full study approval in Italy has been received.

#METHYLOMIC #Omicrohn #enrollment #update

[METHYLOMIC_EU @methylomic]

This week, an article about the EPIC-CD Study was published in The Lancet Gastroenterology and Hepatology

Read and download the article on our website: https://t.co/X0CTO9NjHJ…

#METHYLOMIC #EPICcd #methylation #CrohnsDisease

[METHYLOMIC_EU @methylomic]

Three questions for Roberto Saldaña, EFCCA Innovation and Patient Engagement Coordinator about the METHYLOMIC study:

https://t.co/bDJbYySeZg

#METHYLOMIC

[METHYLOMIC_EU @methylomic]

Soon we will launch a serie of new podcasts. Journalist Shula Tas interviews several people about how methylation research aims to improve treatment selection for Crohn’s, RA and Psoriasis.

https://t.co/VzkvYM6Hev

#METHYLOMIC #TargetingHope #Podcasts

[METHYLOMIC_EU @methylomic]

Last Friday, June 20, nearly 50 partners participating in the METHYLOMIC study gathered in Brussels for the third Network Meeting. Keep an eye on the News page of the METHYLOMIC website for the latest updates: https://t.co/H00kcpHCPi #METHYLOMIC #TargetingHope #NetworkMeeting

[METHYLOMIC_EU @methylomic]

The first participants have been enrolled in the #OMICROHN study. And additional sites are steadily moving toward activation.

Patients have been enrolled in:
➡️ Kings College Hospital in the UK
➡️ AZ Maria Middelares in Belgium
➡️ Amsterdam UMC in the Netherlands

[METHYLOMIC_EU @methylomic]

On Monday 10 March we were in the Amsterdam UMC hospital to record and film four new METHYLOMIC Matters podcasts and videos for patients with Crohn’s Disease, Rheumatoid Arthritis or Psoriasis. The podcasts and videos are also interesting for the general public.

[METHYLOMIC_EU @methylomic]

We are excited to share updates on our progress with you. Read our latest news letter:

https://t.co/TO4D8PYzZP

#METHYLOMIC #OMICROHN #EPIPSORA